USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
INTERVEXION THERAPEUTICS, LLC
Address:
INTERVEXION THERAPEUTICS, LLC
4301 WEST MARKHAM #831
LITTLE ROCK, AR 72205 0719
Phone:
(501) 686-8602
URL:
N/A
EIN:
200743552
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $758,369.00 1
STTR Phase II $2,086,144.00 1

Award List:

Development of Plant Derived Antibodies for Drugs Abuse

Award Year / Program / Phase:
2004 / STTR / Phase I
Award Amount:
$758,369.00
Agency:
HHS
Principal Investigator:
Research Institution:
UNIVERSITY OF ARKANSAS AT LITTLE ROCK
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): The goal of this combination Phase I / Phase II STTR project is to test the hypothesis that anti-drug monoclonal antibodies are a safe and effective therapy for the medical problems associated with phencyclidine (PCP) abuse. There are currently no specific… More

Development of Plant Derived Antibodies for Drugs Abuse

Award Year / Program / Phase:
2006 / STTR / Phase II
Award Amount:
$2,086,144.00
Agency:
HHS
Principal Investigator:
Research Institution:
University of Arkansas
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): The goal of this combination Phase I / Phase II STTR project is to test the hypothesis that anti-drug monoclonal antibodies are a safe and effective therapy for the medical problems associated with phencyclidine (PCP) abuse. There are currently no specific… More